These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A case of pityriasis rubra pilaris associated with membranous nephropathy. Lin CY; Maurice PD; Cross NB Australas J Dermatol; 2013 Feb; 54(1):e1-3. PubMed ID: 23373888 [TBL] [Abstract][Full Text] [Related]
34. Rapid response of erythrodermic pityriasis rubra pilaris to tildrakizumab. Villa-Gonzalez JM; Gonzalez-Hermosa MR; Atxutegi-Ayesta X; Ratón Nieto JA; Gardeazabal García J; Lasa Elgezua O Clin Exp Dermatol; 2024 Jan; 49(2):177-180. PubMed ID: 37847660 [No Abstract] [Full Text] [Related]
35. A review of pityriasis rubra pilaris and rheumatologic associations. Chan H; Liu FT; Naguwa S Clin Dev Immunol; 2004 Mar; 11(1):57-60. PubMed ID: 15154613 [TBL] [Abstract][Full Text] [Related]
36. Etretinate in the treatment of juvenile pityriasis rubra pilaris. Fleissner J; Happle R Arch Dermatol; 1981 Nov; 117(11):749-50. PubMed ID: 7316540 [No Abstract] [Full Text] [Related]
37. Successful treatment of erythrodermic pityriasis rubra pilaris with acitretin. Atzori L; Zanniello R; Lappi A; Pinna AL; Ferreli C; Rongioletti F; Pilloni L Dermatol Ther; 2018 Sep; 31(5):e12694. PubMed ID: 30230135 [No Abstract] [Full Text] [Related]
38. Erythroderma secondary to pityriasis rubra pilaris. Gomez-Moyano E; Crespo-Erchiga A Indian J Med Res; 2019 Aug; 150(2):206-207. PubMed ID: 31670278 [No Abstract] [Full Text] [Related]